Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2019 | Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study | Gastric Cancer |